Los Angeles, CA, November 19 -- In a remarkable medical breakthrough, a team of researchers from the Stanford University, Calif., claim to have developed a drug which increases the levels of norepinephrine, a message-carrying chemical in the brain, thus easing the learning difficulties caused by Down’s syndrome, a chromosomal disorder which affects 5,000 newborns in the United States each year.
Recent comments
6 min 3 sec ago
1 hour 50 min ago
2 hours 21 min ago
2 hours 35 min ago
3 hours 48 min ago
6 hours 33 min ago
7 hours 26 min ago
9 hours 23 min ago
9 hours 45 min ago
12 hours 5 min ago